Moderna

Moderna is a biotechnology company specializing in messenger RNA (mRNA) vaccine and immunotherapy development. The company gained prominence following its COVID-19 vaccine and continues to expand its mRNA platform across multiple therapeutic areas. In recent regulatory progress, Moderna's experimental mRNA-based influenza vaccine secured unanimous support from an FDA advisory panel, with the agency identifying no major safety concerns in its evaluation. This advancement reflects the company's ongoing effort to extend its mRNA technology platform beyond COVID-19 to address other infectious diseases.